October 8, 2014

Pending legislation in the Pennsylvania state legislature is raising the eyebrows of several industry members, including the National Community Pharmacists Association, which stated that the legislation in its current form would "severely limit access to more affordable medications, vastly increase overall healthcare costs to Pennsylvania businesses and citizens and add cumbersome reporting requirements on healthcare providers."

October 8, 2014

The Pharmaceutical Research and Manufacturers of America on Tuesday released a new report highlighting the number of investigational cancer medicines that did not succeed in clinical trials. 

October 7, 2014

According to IRI Sales Data, 52 weeks ending 9/7/2014, Jet-Alert has sold more caffeine tablets than any other brand. Jet-Alert™ fast acting, easy to take caffeine pills have been on store shelves since 1984 and are available in Regular Strength (100mg), Double Strength (200mg) and 200mg Softgel formulas.

October 6, 2014

Specialty drug spending continues to rise and is predicted to grow by more than 16% annually from 2015 to 2018. CVS Health researchers examine the reasons for such dramatic increases in spending and discuss tools to help manage these escalating costs.

October 6, 2014

Healthcare Distribution Management Association released a statement in support of the FDA’s “Know Your Source” campaign.

October 6, 2014

Mylan announced the launch of its lamivudine and zidovudine tablets USP, in 150-mg dosage strength.

October 6, 2014

Walgreens on Monday recognized its more than 27,000 community pharmacists as part of American Pharmacists Month.

October 3, 2014

The Community Anti-Drug Coalitions of America and the Consumer Healthcare Products Association started their National Medicine Abuse Awareness Month on Wednesday to spread awarness around the abuse of over-the-counter medicines.

October 3, 2014

Walgreens had September sales of $6.5 billion, an increase of 9.4% as compared with the same month in fiscal 2014.

October 2, 2014

CVS Health Research Institute published a new Insights Report that reviews the company's key research findings on medication adherence and lays out its goal to increase adherence.

October 2, 2014

CVS Health is thanking its 26,000 pharmacists during American Pharmacists Month for their role in changing the way health care is delivered to increase access, lower costs and improve quality in the company's retail pharmacies, mail service pharmacies and specialty pharmacies nationwide.

October 2, 2014

Rite Aid on Thursday reported $2 billion in sales for the four weeks ended Sept. 27, representing a 4.5% increase over the comparable year-ago period. 

October 1, 2014

October is recognized as American Pharmacists Month and the American Pharmacists Association wants to send a clear message: “Know Your Pharmacist—Know Your Medicine.”

October 1, 2014

Bayer on Wednesday announced it has completed the acquisition of the consumer care business of the U.S. pharmaceuticals group Merck.

 

September 29, 2014

CARE Pharmacies last week announced that they have selected PDX’s Enterprise Pharmacy System as the regional drug chain’s pharmacy system of choice. 

September 29, 2014

Alliance Boots on Monday announced that China Securities Regulatory Commission has approved the group's investment in Nanjing Pharmaceutical Company Limited.

September 29, 2014

According to a report released Monday by Thomson Reuters BioWorld, currently there are 700 follow-on biologics therapies moving through pipelines with many already approved.

September 26, 2014

Actavis on Friday confirmed that it has filed an abbreviated new drug application with the Food and Drug Administration to market buprenorphine transdermal system, a generic version of Butrans from Purdue Pharma. 

September 26, 2014

Boehringer Ingelheim Pharmaceuticals announced that the Food and Drug Administration approved Spiriva Respimat (tiotropium bromide) inhalation spray as a treatment for bronchospasm associated with chronic obstructive pulmonary disease. 

September 26, 2014

As part of its new Women’s Wellness initiative, Schnucks Pharmacies has announced that four different oral breast cancer medications (Letrozole, Megestrol, Anastrozole and Tamoxifen) will be available for $9 with a valid prescription.

September 25, 2014

Celgene Corp. earlier this week announced that the Food and Drug Administration approved Otezla (apremilast) for the treatment of moderate to severe plaque psoriasis. The drug is the first and only PDE4 inhibitor approved for the treatment of plaque psoriasis, according to the company.

September 25, 2014

CVS/pharmacy announced on Thursday that it is marking National Prescription Drug Take Back Day on Saturday, Sept. 27 by renewing its community donation program to support local drug collection efforts by law enforcement.

September 24, 2014

CVS Health has entered into new clinical affiliations with three academic medical centers — the University of Maryland Medical System, University of Texas Medical Branch at Galveston and the University of Alabama at Birmingham Health System — to enhance access to care for patients.

September 24, 2014

Dr. Reddy's Labs on Wednesday announced the launch of levalbuterol inhalation solution, USP in 0.31-mg, 0.63-mg and 1.25-mg unit-dose vials.